Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

NCT00122447 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Impaired Glucose Tolerance
Prediabetic State

Interventions

DRUG: Aspirin
DRUG: Alpha lipoic acid
DRUG: Olmesartan
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]